What is the difference between Vigabatrin and Vigabatrin

Vigabatrin and Vigabatrin (Vigabatrin) are essentially the same drug, and the difference between them is only reflected in their naming. Vigabatrin is the international nonproprietary name (INN) of the drug, while Vigabatrin is the trade name of vigabatrin in the Chinese market. Although the names are different, their ingredients and pharmacological effects are exactly the same. Vigabatrin (vigabatrin), as an anti- epilepsy drug, is mainly used to treat some refractory types of epilepsy, especially those patients who are unresponsive to conventional drug treatment. It controls epileptic seizures by enhancing the activity of gamma-aminobutyric acid (GABA) in the brain, thereby inhibiting overactive nerve signals.

VigabatrinThe treatment scope of Vigabatrin/Vigabatrin mainly includes refractory epilepsy, infantile spasms and partial epileptic seizures. It is particularly useful for people with epilepsy who have frequent seizures and for whom other medications are not effective. Compared with traditional anti-epileptic drugs, this drug has unique pharmacological properties and can play a significant role in treating specific types of epilepsy.

Vigabatrin (vigabatrin) is also available in flexible dosage forms, mainly in the form of oral tablets and oral solutions. Among them, oral solutions are particularly suitable for children and other special groups who cannot swallow pills. In China, Vigabatrin’s oral solution has been included in medical insurance, which greatly facilitates patients’ access and use. For epilepsy patients who cannot benefit from other drugs, the efficacy of Vigabatrin has been recognized by many clinicians.

It is worth noting that although vigabatrin has various trade names around the world, and Vigabatrin is a trade name specially named for the Chinese market, their pharmacological properties and clinical applications are completely consistent. The different names are simply to suit the regulatory requirements and commercial needs of each market.

Reference materials:https://www.sabril.net/